Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
NKGen Biotech (NKGN) has issued an announcement.
Pierre Gagnon has stepped down from his role as Chief Operating Officer of NKGen Biotech, Inc., effective immediately, though there is no indication that his resignation is due to disagreements with the company’s operations or practices. Gagnon will remain involved with the company in a non-executive capacity to offer transition and advisory services until the end of November 2024. The company cautions that its forward-looking statements in the report carry risks and uncertainties, advising investors not to rely too heavily on them as they are based on current expectations which are subject to change.
Learn more about NKGN stock on TipRanks’ Stock Analysis page.
